Preliminary results from a phase 2 single-arm study of enzalutamide, an androgen receptor (AR) inhibitor, in advanced AR+ triple-negative breast cancer (TNBC) Meeting Abstract

  

Authors:	Traina, T. A.; O'Shaughnessy, J.; Nanda, R.; Schwartzberg, L.; Abramson, V.; Cortes, J.; Peterson, A.; Tudor, I. C.; Blaney, M.; Steinberg, J. L.; Kelly, C.; Trudeau, M.; Awada, A.; Winer, E.; Hudis, C.; Schmid, P.; Yardley, D. A.
Abstract Title:	Preliminary results from a phase 2 single-arm study of enzalutamide, an androgen receptor (AR) inhibitor, in advanced AR+ triple-negative breast cancer (TNBC)
Meeting Title:	37th Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS)
Journal Title:	Cancer Research
Volume:	75
Issue:	9 Suppl.
Meeting Dates:	2014 Dec 9-13
Meeting Location:	San Antonio, TX
ISSN:	0008-5472
Publisher:	American Association for Cancer Research
Date Published:	2015-05-01
Language:	English
ACCESSION:	WOS:000356730203161
DOI:	10.1158/1538-7445.sabcs14-p5-19-09
PROVIDER:	wos
Notes:	Meeting Abstract: P5-19-09 -- 37th Annual CTRC-AACR San Antonio Breast Cancer Symposium -- DEC 09-13, 2014 -- San Antonio, TX -- S -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/77262